These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 12844221)

  • 1. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
    Kellerer AM; Nekolla E
    Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS; Endo S; Hoshi M; Nomura T
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable chromosome aberrations among A-bomb survivors: an update.
    Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
    Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
    Cordova KA; Cullings HM
    Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of neutrons in Hiroshima. Implications for the risk estimates.
    Kellerer AM
    C R Acad Sci III; 1999; 322(2-3):229-37. PubMed ID: 10196677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
    Stram DO; Mizuno S
    Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
    Nagatomo T; Ichikawa Y; Hoshi M
    J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
    Little MP
    Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutron-induced 63Ni in copper samples from Hiroshima and Nagasaki: a comprehensive presentation of results obtained at the Munich Maier-Leibnitz Laboratory.
    Rühm W; Carroll KL; Egbert SD; Faestermann T; Knie K; Korschinek G; Martinelli RE; Marchetti AA; McAninch JE; Rugel G; Straume T; Wallner A; Wallner C; Fujita S; Hasai H; Hoshi M; Shizuma K
    Radiat Environ Biophys; 2007 Nov; 46(4):327-38. PubMed ID: 17828415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the discrepancy between calculated and measured neutron-induced radioactivity levels in Hiroshima.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):345-56. PubMed ID: 12546223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
    Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
    Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.